최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Korean journal of clinical laboratory science : KJCLS = 대한임상검사과학회지, v.53 no.3, 2021년, pp.225 - 232
김지우 (가톨릭관동대학교 국제성모병원 진단검사의학과) , 주효진 (가톨릭관동대학교 의과대학 인문학교실) , 구제현 (가톨릭관동대학교 국제성모병원 진단검사의학과) , 이혜영 (가톨릭관동대학교 국제성모병원 진단검사의학과) , 박현환 (가톨릭관동대학교 보건의료융합연구소) , 송경철 (가톨릭관동대학교 국제성모병원 진단검사의학과) , 김자영 (가톨릭관동대학교 국제성모병원 진단검사의학과)
This study sought to investigate the distribution, antimicrobial resistance rate, and bacterial co-infection frequency of non-tuberculous mycobacteria (NTM) in a single center in Incheon, South Korea. A total of 8,258 specimens submitted for tuberculosis (TB)/NTM real-time PCR tests during the years...
Park YM, Kim CY, Park MS, Kim YS, Chang J, Kang YA. Age-and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016. Korean J Intern Med. 2020;35:1424-1431. https://doi.org/10.3904/kjim.2019.395
Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167: 828-834. https://doi.org/10.1164/rccm.200207-678OC
Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23:529-551. https://doi.org/10.1016/s0272-5231(02)00014-x
Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med. 2002;23:553-567. https://doi.org/10.1016/s0272-5231(02)00019-9
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152:185-226. https://doi.org/10.4103/ijmr.IJMR_902_20
WHO. Global tuberculosis report 2018. Geneva: WHO; 2018.
Hoefsloot W, Ingen JV, Andrejak C, Ngeby KA, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples. Eur Respir J. 2013;42: 1604-1613. https://doi.org/10.1183/09031936.00149212
Primm TP, Lucero CA, Falkinham JO 3rd, Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106. https://doi.org/10.1128/CMR.17.1.98_106.2004
Park SC, Kang MJ, Han CH, Lee SM, Kim CJ, Lee JM, et al. Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study. BMC Pulmonary Medicine. 2019;19:140-148. https://doi.org/10.1186/s12890-019-0901-z
Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-3rd ed, M24-M62. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean Guidelines for Tuberculosis. 4th ed. 2020.
Huh KM, Jung JH, Hong JW, Kim MY, Ahn JG, Kim JH, et al. Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: a nationwide surveillance study. Clin Infect Dis. 2021;72:184-191. https://doi.org/10.1093/cid/ciaa1682
Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc. 2015;12:642-647. https://doi.org/10.1513/AnnalsATS.201412-559OC
Daley CL, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553-567. https://doi.org/10.1016/S0272-5231(02)00019-9
Sakatani M. The non-tuberculous mycobacteriosis. Kekkaku. 2005;80:25-30.
Kim NH, Yi JY, Chang CL. Recovery rates of non-tuberculous mycobacteria from clinical specimens are increasing in Korean tertiary-care hospitals. J Korean Med Sci. 2017;32:1263-1267. https://doi.org/10.3346/jkms.2017.32.8.1263
Jankovic M, Samarziha M, Sabol I, Jakopivic M, Jankovic K, Zmak L, et al. Geographical distribution and clinical relevanceof non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis. 2013;17:836-841. https://doi.org/10.5588/ijtld.12.0843
Van lugen J, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, Van soolingen D. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis. 2010;14: 1176-1180. PMID: 20819265
Panagiotou M, Papaioannou AI, Kostikas K, Paraskeua M, Velentza E, Kanellopoulou M, et al. The epidemiology of pulmonary nontuberculous mycobacteria: data from a general hospital in Athens, Greece, 2007-2013. Pulm Med. 2014;2014:894976. https://doi.org/10.1155/2014/894976
Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-3rd ed, M24. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
Lee SH, Yoo HK, Kim SH, Koh WJ, Kim CK, Park YK, et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea. Ann Lab Med. 2014;34:31-37. https://doi.org/10.3343/alm.2014.34.1.31
Jeon KM, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180:896-902. https://doi.org/10.1164/rccm.200905-0704OC
Gorsich EE, Etienne RS, Medlock J, Beechler BR, Spaan M, Spaan RS, et al. Opposite outcomes of coinfection at individual and population scales. PNAS. 2018;115:7545-7550. https://doi.org/10.1073/pnas.1801095115
Geurts K, Zweijpfenning SMH, Pennings LJ, Schildkraut JA, Boeree MJ, MagisEscurra C, et al. Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: bonnie and clyde?. Eur Respir J. 2019;54:1900117. https://doi.org/10.1183/13993003.00117-2019
Lim YK, Kweon OH, Kim HR, Kim TH, Lee MK. Impact of bacterial and viral coinfection in community-acquired pneumonia in adults. Diagn Microbiol Infect Dis. 2019;94:50-54. https://doi.org/10.1016/j.diagmicrobio.2018.11.014
※ AI-Helper는 부적절한 답변을 할 수 있습니다.